Trinity Biotech (Trinity Biotech) 3-Year Revenue Growth Rate : -14.50% (As of Sep. 2023)

View and export this data going back to 1995. Start your Free Trial

What is Trinity Biotech 3-Year Revenue Growth Rate?

Trinity Biotech's Revenue per Share for the three months ended in Sep. 2023 was $1.92.

During the past 12 months, Trinity Biotech's average Revenue per Share Growth Rate was -23.40% per year. During the past 3 years, the average Revenue per Share Growth Rate was -14.50% per year. During the past 5 years, the average Revenue per Share Growth Rate was -4.80% per year. During the past 10 years, the average Revenue per Share Growth Rate was -1.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Trinity Biotech was 79.40% per year. The lowest was -30.90% per year. And the median was 0.55% per year.

Competitive Comparison of Trinity Biotech's 3-Year Revenue Growth Rate

For the Diagnostics & Research subindustry, Trinity Biotech's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Trinity Biotech's 3-Year Revenue Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Trinity Biotech's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Trinity Biotech's 3-Year Revenue Growth Rate falls into.

Trinity Biotech 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Trinity Biotech (NAS:TRIB) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Trinity Biotech 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Trinity Biotech's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Trinity Biotech (Trinity Biotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Trinity Biotech PLC (NAS:TRIB) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

TRBA:Germany

Address

IDA Business Park, Bray, County Wicklow, Dublin, IRL, A98 H5C8

Website

https://www.trinitybiotech.com

Trinity Biotech PLC is in the business of development, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point of care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Premier, Immublot, EZ, Capita, and others. Geographically, it has two segments namely the Americas, and Rest of World - Ireland of which it derives a majority of its revenues from the Americas segment.